LeonaBio LONA
NASDAQ LONA
$7.68 -0.01 (-0.19%)
At close: Aug 21, 2026 · 4:00 PM EDT

LeonaBio (LONA) Debt Ratio (2022 - 2024)

LeonaBio (LONA) posted quarterly Debt Ratio of 0.12 for Q3 2024, up 114.15% year-over-year from 0.05 in Q4 2023, and up 28.99% quarter-over-quarter from 0.09 in Q2 2024.

LeonaBio (LONA) Debt Ratio (2022 - 2024) Analysis & Trends

LeonaBio (LONA) has reported Debt Ratio for 3 consecutive years, with 0.12 the latest figure, recorded in Q3 2024.

  • In Q3 2024, Debt Ratio rose 114.15% year-over-year to 0.12; the TTM figure through Sep 2024 stood at 0.12 (up 114.15% YoY), while the FY2023 annual figure was 0.06, up 61.1% from the prior year.
  • Debt Ratio improved to 0.12 in Q3 2024 per LONA's latest filing, from 0.09 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.12 in Q3 2024 and bottomed at 0.04 in Q4 2022.
  • Historically, Debt Ratio has averaged 0.07 across 3 years, with a median of 0.06 in 2023.
  • Annual changes were most pronounced in 2023 — Debt Ratio surged 61.1% — and 2024, when it jumped 114.15%.
  • LeonaBio's Debt Ratio stood at 0.04 in 2022, then soared by 61.1% to 0.06 in 2023, then soared by 85.8% to 0.12 in 2024.
  • Business Quant data shows LONA's Debt Ratio at 0.12 in Q3 2024, 0.09 in Q2 2024, and 0.07 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 0.05
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 0.05
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 0.12
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 0.03
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
9 Royalty Pharma 27.27 Bn 26.43 Bn - 0.47
10 LeonaBio 180.91 Mn 129.85 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 0.12
Jun 30, 2024 0.09
Mar 31, 2024 0.07
Dec 31, 2023 0.06
Sep 30, 2023 0.05
Jun 30, 2023 0.05
Mar 31, 2023 0.04
Dec 31, 2022 0.04